Any temporary reduction in blood pressure is not to be regarded as a long-term advantage of the medication
How PlexusDx Supports a More Personalized Approach PlexusDx genetic testing reveals predispositions in GLP1R, MC4R, and FTO pathways that may help provide context for how aggressively your appetite hormones rebound and how quickly your metabolic rate adapts after discontinuation
Muscle Mass and Bone Density - The loss of lean muscle mass can have serious impacts on a GLP-1 user's ability to keep weight off post-treatment and comes with the concerning loss of bone density
Volling K, Thywissen A, Brakhage AA, Saluz HP
Using chimeric Lurcher mice in this task helped to estimate the effect of PCs degradation on cognitive processing, as the chimeric Lurcher mice, with some healthy PCs, made fewer errors than Lurcher mice with no Purkinje cells and more errors than WT mice in the reversed task
This FDA-approved treatment is specifically designed for weight management, distinguishing it from its tirzepatide cousin, Mounjaro, which targets type 2 diabetes
